PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer

ConclusionsPD-1 seems to be less often expressed in male breast cancer compared to female breast cancer. Although PD-1 and PD-L1 are not definite indicators for good or bad responses, male breast cancer patients may therefore respond differently to checkpoint immunotherapy with PD-1 inhibitors than female patients.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research